Treasurer of the State of North Carolina’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-42,340
| Closed | -$921K | – | 1132 |
|
|
2026
Q1 | $921K | Buy |
42,340
+3,486
| +9% | +$67.5K | ﹤0.01% | 948 |
|
|
2025
Q4 | $836K | Sell |
38,854
-2,837
| -7% | -$59.8K | ﹤0.01% | 967 |
|
|
2025
Q3 | $803K | Sell |
41,691
-1,630
| -4% | -$29.1K | ﹤0.01% | 983 |
|
|
2025
Q2 | $741K | Buy |
43,321
+1,433
| +3% | +$61.1K | ﹤0.01% | 996 |
|
|
2025
Q1 | $2.67M | Sell |
41,888
-19,470
| -32% | -$2.05M | 0.01% | 796 |
|
|
2024
Q4 | $7.46M | Sell |
61,358
-1,000
| -2% | -$123K | 0.03% | 486 |
|
|
2024
Q3 | $7.79M | Buy |
62,358
+860
| +1% | +$119K | 0.03% | 482 |
|
|
2024
Q2 | $9.72M | Sell |
61,498
-809
| -1% | -$104K | 0.04% | 390 |
|
|
2024
Q1 | $8.07M | Buy |
62,307
+22,630
| +57% | +$2.77M | 0.04% | 446 |
|
|
2023
Q4 | $3.83M | Sell |
39,677
-22,235
| -36% | -$2.13M | 0.02% | 648 |
|
|
2023
Q3 | $7.5M | Sell |
61,912
-750
| -1% | -$84.8K | 0.04% | 414 |
|
|
2023
Q2 | $7.18M | Buy |
62,662
+2,355
| +4% | +$304K | 0.04% | 438 |
|
|
2023
Q1 | $8.31M | Sell |
60,307
-270
| -0.4% | -$35K | 0.05% | 385 |
|
|
2022
Q4 | $7.85M | Buy |
60,577
+10,430
| +21% | +$1.21M | 0.05% | 394 |
|
|
2022
Q3 | $5.54M | Buy |
50,147
+14,550
| +41% | +$1.47M | 0.04% | 451 |
|
|
2022
Q2 | $2.67M | Buy |
35,597
+4,914
| +16% | +$362K | 0.02% | 704 |
|
|
2022
Q1 | $2.4M | Buy |
30,683
+485
| +2% | +$37.1K | 0.01% | 750 |
|
|
2021
Q4 | $2.72M | Buy |
30,198
+2,710
| +10% | +$232K | 0.01% | 720 |
|
|
2021
Q3 | $2.54M | Buy |
27,488
+929
| +3% | +$71.6K | 0.01% | 735 |
|
|
2021
Q2 | $2.06M | Sell |
26,559
-1,070
| -4% | -$81.1K | 0.01% | 821 |
|
|
2021
Q1 | $2.06M | Sell |
27,629
-22,151
| -44% | -$2.04M | 0.01% | 780 |
|
|
2020
Q4 | $8.49M | Sell |
49,780
-210
| -0.4% | -$31.1K | 0.06% | 320 |
|
|
2020
Q3 | $7.02M | Sell |
49,990
-350
| -0.7% | -$53.2K | 0.05% | 323 |
|
|
2020
Q2 | $8.07M | Buy |
50,340
+12,540
| +33% | +$1.71M | 0.07% | 273 |
|
|
2020
Q1 | $3.7M | Buy |
37,800
+12,200
| +48% | +$1.39M | 0.03% | 438 |
|
|
2019
Q4 | $3.3M | Buy |
25,600
+1,790
| +8% | +$181K | 0.03% | 425 |
|
|
2019
Q3 | $1.79M | Sell |
23,810
-5,610
| -19% | -$663K | 0.02% | 604 |
|
|
2019
Q2 | $4.47M | Sell |
29,420
-4,290
| -13% | -$521K | 0.03% | 510 |
|
|
2019
Q1 | $4.02M | Sell |
33,710
-2,159
| -6% | -$278K | 0.03% | 526 |
|
|
2018
Q4 | $3.91M | Buy |
35,869
+1,645
| +5% | +$206K | 0.03% | 491 |
|
|
2018
Q3 | $5.53M | Buy |
34,224
+20,288
| +146% | +$2.77M | 0.03% | 433 |
|
|
2018
Q2 | $1.84M | Buy |
+13,936
| New | +$1.31M | 0.02% | 617 |
|
Other funds holding SRPT
EAM
Treasurer of the State of North Carolina's SRPT Position: Q2 2026 in Review
Treasurer of the State of North Carolina sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 42,340 shares — an estimated $921K sold.
Treasurer of the State of North Carolina first reported a position in SRPT in Q2 2018 and held it in 32 quarters. The position peaked at $9.72M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Treasurer of the State of North Carolina reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Treasurer of the State of North Carolina sold 42,340 Sarepta Therapeutics shares in Q2 2026, an estimated $921K.
- Treasurer of the State of North Carolina first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 32 quarters.
- Treasurer of the State of North Carolina's Sarepta Therapeutics position peaked at $9.72M in Q2 2024.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.